158 related articles for article (PubMed ID: 21730821)
1. Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy.
Kim H; Zhai G; Liu Z; Samuel S; Shah N; Helman EE; Knowles JA; Stockard CR; Fineberg NS; Grizzle WE; Zhou T; Zinn KR; Rosenthal EL
Anticancer Drugs; 2011 Oct; 22(9):864-74. PubMed ID: 21730821
[TBL] [Abstract][Full Text] [Related]
2. Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
Kim H; Zhai G; Samuel SL; Rigell CJ; Umphrey HR; Rana S; Stockard CR; Fineberg NS; Zinn KR
Mol Cancer Ther; 2012 Feb; 11(2):405-15. PubMed ID: 22203731
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts.
Shah N; Zhai G; Knowles JA; Stockard CR; Grizzle WE; Fineberg N; Zhou T; Zinn KR; Rosenthal EL; Kim H
Mol Imaging Biol; 2012 Apr; 14(2):237-44. PubMed ID: 21494920
[TBL] [Abstract][Full Text] [Related]
4. Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.
Dean NR; Newman JR; Helman EE; Zhang W; Safavy S; Weeks DM; Cunningham M; Snyder LA; Tang Y; Yan L; McNally LR; Buchsbaum DJ; Rosenthal EL
Clin Cancer Res; 2009 Jun; 15(12):4058-65. PubMed ID: 19509148
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers.
Kim H; Rigell CJ; Zhai G; Lee SK; Samuel SL; Martin A; Umphrey HR; Stockard CR; Beasley TM; Buchsbaum DJ; Li LS; Boothman DA; Zinn KR
Mol Imaging Biol; 2014 Feb; 16(1):85-94. PubMed ID: 23836505
[TBL] [Abstract][Full Text] [Related]
6. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
[TBL] [Abstract][Full Text] [Related]
7. Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer.
Newman JR; Bohannon IA; Zhang W; Skipper JB; Grizzle WE; Rosenthal EL
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1218-24. PubMed ID: 19015455
[TBL] [Abstract][Full Text] [Related]
8. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in pancreatic neoplasm and pancreatic stellate cells.
Zhang W; Erkan M; Abiatari I; Giese NA; Felix K; Kayed H; Büchler MW; Friess H; Kleeff J
Cancer Biol Ther; 2007 Feb; 6(2):218-27. PubMed ID: 17224648
[TBL] [Abstract][Full Text] [Related]
9. A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Agrawal SM; Silva C; Wang J; Tong JP; Yong VW
J Neuroinflammation; 2012 Apr; 9():64. PubMed ID: 22480370
[TBL] [Abstract][Full Text] [Related]
10. Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model.
Dean NR; Knowles JA; Helman EE; Aldridge JC; Carroll WR; Magnuson JS; Clemons L; Ziober B; Rosenthal EL
Anticancer Drugs; 2010 Oct; 21(9):861-7. PubMed ID: 20700044
[TBL] [Abstract][Full Text] [Related]
11. [Observation of the antitumor effect of endostar combined with docetaxel under different administration sequences].
Yuan J; Wu CW; Liu ZJ; Wei XY; Li K
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):580-5. PubMed ID: 21122408
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
Kim HS; Kim HJ; Lee MR; Han I
BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
[TBL] [Abstract][Full Text] [Related]
13. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts.
Li R; Huang L; Guo H; Toole BP
J Cell Physiol; 2001 Mar; 186(3):371-9. PubMed ID: 11169976
[TBL] [Abstract][Full Text] [Related]
14. EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis.
Agrawal SM; Silva C; Tourtellotte WW; Yong VW
J Neurosci; 2011 Jan; 31(2):669-77. PubMed ID: 21228176
[TBL] [Abstract][Full Text] [Related]
15. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle.
Mishra B; Kizaki K; Koshi K; Ushizawa K; Takahashi T; Hosoe M; Sato T; Ito A; Hashizume K
Reprod Biol Endocrinol; 2010 Jun; 8():60. PubMed ID: 20540754
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
[TBL] [Abstract][Full Text] [Related]
17. Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer) stimulates the migration of HEp-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts.
Hanata K; Yamaguchi N; Yoshikawa K; Mezaki Y; Miura M; Suzuki S; Senoo H; Ishikawa K
Arch Histol Cytol; 2007 Dec; 70(5):267-77. PubMed ID: 18431027
[TBL] [Abstract][Full Text] [Related]
18. Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide.
Ramirez-Carracedo R; Tesoro L; Hernandez I; Diez-Mata J; Filice M; Toro R; Rodriguez-Piñero M; Zamorano JL; Saura M; Zaragoza C
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347750
[TBL] [Abstract][Full Text] [Related]
19. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Cancer Lett; 2000 Sep; 157(2):177-84. PubMed ID: 10936678
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats.
Donadio AC; Remedi MM; Susperreguy S; Frede S; Gilardoni MB; Tang Y; Pellizas CG; Yan L
Histochem Cell Biol; 2008 Dec; 130(6):1155-64. PubMed ID: 18769934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
